Pemoline is a stimulant drug of the 4-oxazolidinone class. It was first synthesized
in 1913 but its activity was not discovered until the 1930s. Under the names ...
Physician reviewed pemoline patient information - includes pemoline description,
dosage and directions.
Dec 8, 2004 ... Because of its association with life threatening hepatic failure, CYLERT (
pemoline) should not ordinarily be considered as first line drug therapy ...
Get information pemoline (Cylert), an ADD drug removed from the US market in
the United States.
CYLERT (pemoline) is a central nervous system stimulant. Pemoline is ...
CYLERT (pemoline) is supplied as tablets containing 18.75 mg, 37.5 mg or 75
Description, In 2005, the Food and Drug Administration (FDA) withdrew approval
for pemoline. In March 2005, Abbott Laboratories (Cylert marketer) had ...
Pemoline Brand Name: Cylert - now discontinued. Overview Cylert is the brand
name for Pemoline – CNS (central nervous system) stimulant. This drug may ...
J Clin Psychopharmacol. 1999 Jun;19(3):257-64. Controlled trial of high doses of
pemoline for adults with attention-deficit/hyperactivity disorder. Wilens TE(1) ...
Mar 24, 2005 ...  Between the 1975 approval and 1996, there were 193 adverse drug reactions
involving the liver ascribed to pemoline reported to the FDA ...
Pemoline, first synthesized in 1913, is a CNS stimulant of the lesser known
chemical family of oxazolines. The only other widely known member of this family